[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Geordan G. Pursglove", "age": 36, "title": "CEO, President & Chairman", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter M. Stazzone", "age": 73, "title": "Chief Financial Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0, "open": 0.1699, "dayLow": 0.1557, "dayHigh": 0.1699, "regularMarketPreviousClose": 0.0, "regularMarketOpen": 0.1699, "regularMarketDayLow": 0.1557, "regularMarketDayHigh": 0.1699, "beta": 0.892, "volume": 1174, "regularMarketVolume": 1174, "averageVolume": 24045, "averageVolume10days": 72550, "averageDailyVolume10Day": 72550, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.38, "allTimeHigh": 6.77, "allTimeLow": 0.01, "fiftyDayAverage": 0.13048, "twoHundredDayAverage": 0.10506, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": "NaN", "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 5693191, "bookValue": 0.414, "priceToBook": 0.05338164, "netIncomeToCommon": -4133687, "52WeekChange": 0.047619104, "SandP52WeekChange": 0.14272952, "quoteType": "EQUITY", "currentPrice": 0.0221, "recommendationKey": "none", "totalCash": 2887874, "totalCashPerShare": 0.506, "totalDebt": 0, "quickRatio": 5.538, "currentRatio": 10.421, "returnOnAssets": -0.68318003, "returnOnEquity": -1.30059, "freeCashflow": -3476484, "operatingCashflow": -2581395, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXTW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1769806800, "exchange": "NGM", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1606487400000, "regularMarketChange": 0.0221, "regularMarketDayRange": "0.1557 - 0.1699", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 24045, "fiftyTwoWeekLowChange": 0.0121, "fiftyTwoWeekLowChangePercent": 1.21, "fiftyTwoWeekRange": "0.01 - 0.38", "fiftyTwoWeekHighChange": -0.3579, "fiftyTwoWeekHighChangePercent": -0.9418421, "fiftyTwoWeekChangePercent": 4.7619104, "fiftyDayAverageChange": -0.108380005, "fiftyDayAverageChangePercent": -0.83062536, "twoHundredDayAverageChange": -0.08296, "twoHundredDayAverageChangePercent": -0.789644, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": -2.6266396, "regularMarketPrice": 0.0221, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]